- Home
- Standardized Extracts
- Narrow-leaf Echinacea Extract
Narrow-leaf Echinacea Extract (Echinacea angustifolia) – Echinacoside 2–4%
Echinacea angustifolia
- Marker compound
- Echinacoside
- Standardisation
- 2–4% (HPLC)
- Assay method
- HPLC
- Plant part
- Root
- Origin
- United States
Narrow-leaf Echinacea Extract (Echinacea angustifolia) – Echinacoside 2–4%
Narrow-leaf Echinacea extract is produced from the root of Echinacea angustifolia (Asteraceae family) and supplied as a standardized extract powder, standardized to Echinacoside. Available grades: 2%, 4%. Typical sourcing: United States. For B2B formulation in nutraceuticals & supplements.
2%4%
Specifications
| Botanical name | Echinacea angustifolia |
| Common names | Narrow-leaf echinacea |
| Plant family / part | Asteraceae / Root |
| Marker compound | Echinacoside |
| Phytochemical class | Polyphenols › Phenylethanoids & phenylpropanoid glycosides |
| Available grades | 2%, 4% |
| Assay method | HPLC |
| Pharmacopoeia & standards | USP, Ph. Eur. (EP), EMA herbal monograph, WHO monograph |
| Form | Standardized Extract |
| Origin | United States |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Immune Support
Industries
Nutraceuticals & Supplements
Traditional systems: European herbal tradition, North American herbal tradition
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form